Jeremy Green, 10% Owner at Neoleukin Therapeutics, Inc. (NLTX), bought 244,300 shares at $11.36 ($2.5M) on 2020-04-02, disclosed to the SEC on 2020-04-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.21 | 50,000 | $461K | 18.6% |
| 2 | $9.21 | 50,000 | $461K | 18.6% |
| 3 | $9.91 | 29,800 | $295K | 11.9% |
| 4 | $10.27 | 2,700 | $28K | 1.1% |
| 5 | $10.18 | 22,500 | $229K | 9.3% |
| 6 | $10.71 | 7,500 |
| $80K |
| 3.2% |
| 7 | $10.95 | 33,500 | $367K | 14.8% |
| 8 | $11.65 | 9,000 | $105K | 4.2% |
| 9 | $11.36 | 38,300 | $435K | 17.6% |
| 10 | $11.85 | 1,000 | $12K | 0.5% |
| Total | $10.12 avg | 244,300 | $2.5M | 100% |
| Filing → |
| ADCT | BUY | 2024-12-13 | $419K | — | Filing → |
| STTK | BUY | 2024-12-06 | $333K | — | Filing → |
| STTK | SELL | 2024-12-06 | $333K | — | Filing → |